↓ Skip to main content

LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling

Overview of attention for article published in Frontiers in immunology, April 2023
Altmetric Badge

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling
Published in
Frontiers in immunology, April 2023
DOI 10.3389/fimmu.2023.1179827
Pubmed ID
Authors

Arya Afsahi, Christopher M. Silvestri, Allyson E. Moore, Carly F. Graham, Kaylyn Bacchiochi, Martine St-Jean, Christopher L. Baker, Robert G. Korneluk, Shawn T. Beug, Eric C. LaCasse, Jonathan L. Bramson

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 50%
Unknown 1 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 50%
Unknown 1 50%